Celator(R) Pharmaceuticals Announces Participation in Cardiff University Clinical Trial in Adults with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome (AML19)
January 11, 2016Clinical trials with CPX-351 have shown improved efficacy and reduced early mortality in the majority of patients studied directly supporting evaluating CPX-351 in these patient populations.
More »
Tobira Therapeutics Announces Initiation of Program to Evaluate Cenicriviroc for the Treatment of Primary Sclerosing Cholangitis
January 7, 2016Tobira Therapeutics announced that the FDA and Health Canada have accepted the company's IND and CTA applications, respectively, for cenicriviroc for the treatment of primary sclerosing cholangitis.
More »
Veracyte Announces Expansion to New South San Francisco Facility
January 7, 2016The move accommodates a strong growth as the company expands its genomic test offerings designed to improve disease diagnosis, thus helping patients avoid unnecessary surgeries and taking costs out of the healthcare system.
More »